Dr. Hsu founded TaiGen in 2001, after successfully building the Biotechnology and Pharmaceutical Research Division at the National Health Research Institutes in Taiwan. She was the first Program Leader of the National Biotechnology/Pharmaceutical Research Program under the National Science Council, bringing together 62 academic laboratories to conduct mission-oriented research. Before her return to Taiwan in 1998, Dr. Hsu held the position of Research Director, Oncology and Virology at Hoffmann-La Roche, USA for over 10 years. Prior to that, Dr. Hsu was an assistant professor at Rockefeller University, New York, and a Research Fellow at the California Institute of Technology and at Stanford University. Dr. Hsu obtained her Ph.D. degree in biochemistry from the University of Illinois. Dr. Hsu has extensive experience in establishing world-class drug discovery teams and clinical development programs. At TaiGen she has led the R&D team to successfully discover and develop 3 new drugs, for bacterial resistant infection, HCV chronic infection and stem cell mobilization for cancer treatment and for ischemic tissue repair.